Iradimed Corp
IRMD
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.09B
Close$
$49.78
41.3% downside
Current Fair Value
41.3% downsideOvervalued by 41.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.09 Billion |
|---|---|
| Enterprise Value | $1.04 Billion |
| Dividend Yield | $1.27 (1.49%) |
| Earnings per Share | $1.77 |
| Beta | 0.9 |
| Outstanding Shares | 12,784,000 |
Return
| Return on Equity | 22.66% |
|---|---|
| Return on Assets | 20.05% |
| Return on Invested Capital | 26.91% |
Valuation & Multiples
| P/E Ratio | 46.92 |
|---|---|
| PEG | -487.32 |
| Price to Sales | 14.14 |
| Price to Book Ratio | 12.12 |
| Enterprise Value to Revenue | 12 |
| Enterprise Value to EBIT | 36.39 |
| Enterprise Value to Net Income | 44 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 31, 2026
EPS Estimate
$0.44
Average shareholder expectationRevenue Estimate
$20.35 M
Average shareholder expectationNext Earnings Call
Expected Date
November 2, 2026
EPS Estimate
$0.55
Average shareholder expectationRevenue Estimate
$23.43 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.2222▲ 45.85% |
|---|---|
| Total Calls | 13,500▼ 56.31% |
| Total Puts | 16,500▼ 30.08% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 61.96%▲ 2.27% |
|---|---|
| Total Invested | $756.82M▲ 3.06% |
| Investors Holding | 218▼ 14.00% |
ESG Score
No data
About Iradimed Corp
CEO: Roger Susi